Business Description
Teladoc Health Inc
NAICS : 621999
SIC : 8011
ISIN : US87918A1051
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.71 | |||||
Equity-to-Asset | 0.53 | |||||
Debt-to-Equity | 0.69 | |||||
Debt-to-EBITDA | 10.32 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -3.47 | |||||
Beneish M-Score | -3.1 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.4 | |||||
3-Year EPS without NRI Growth Rate | 36.2 | |||||
3-Year Book Growth Rate | -49.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | -29.03 | |||||
Future 3-5Y Total Revenue Growth Rate | 3.23 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 52.39 | |||||
9-Day RSI | 44.64 | |||||
14-Day RSI | 41.71 | |||||
6-1 Month Momentum % | -20.88 | |||||
12-1 Month Momentum % | -44.53 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.54 | |||||
Quick Ratio | 3.47 | |||||
Cash Ratio | 2.67 | |||||
Days Inventory | 19.37 | |||||
Days Sales Outstanding | 29.87 | |||||
Days Payable | 16.52 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.5 | |||||
Shareholder Yield % | 0.07 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 70.8 | |||||
Operating Margin % | -8.09 | |||||
Net Margin % | -8.47 | |||||
FCF Margin % | 7.41 | |||||
ROE % | -9.57 | |||||
ROA % | -5.08 | |||||
ROIC % | -6.57 | |||||
ROC (Joel Greenblatt) % | -283.46 | |||||
ROCE % | -5 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 36.64 | |||||
PS Ratio | 0.84 | |||||
PB Ratio | 0.95 | |||||
Price-to-Free-Cash-Flow | 11.37 | |||||
Price-to-Operating-Cash-Flow | 6.27 | |||||
EV-to-EBIT | -14.18 | |||||
EV-to-Forward-EBIT | -40.18 | |||||
EV-to-EBITDA | 18.13 | |||||
EV-to-Forward-EBITDA | 10.68 | |||||
EV-to-Revenue | 1.08 | |||||
EV-to-Forward-Revenue | 1.05 | |||||
EV-to-FCF | 14.05 | |||||
Price-to-Projected-FCF | 0.92 | |||||
Earnings Yield (Greenblatt) % | -7.05 | |||||
FCF Yield % | 8.32 |